Smith, Moore & Co. Iridex Corp Transaction History
Smith, Moore & Co.
- $1.03 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding IRIX
# of Institutions
25Shares Held
3.12MCall Options Held
0Put Options Held
2K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$940,0002.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA595KShares$559,0990.0% of portfolio
-
Amh Equity LTD519KShares$487,4280.83% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$356,4100.0% of portfolio
-
Geode Capital Management, LLC Boston, MA133KShares$125,1180.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $15M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...